GPR143 and ocular albinism: There are emerging gene-based applications for treating albinism [24] such as adeno-associated virus (AAV)-based Oa1 gene therapy which has been demonstrated in knockout mice models for ocular albinism [25] and with Tyr oculocutaneous albinism type 1 [26].